Multidrug resistance-associated protein 1 as a major mediator of basal and apoptotic glutathione release

Rosemarie Marchan1, Christine L Hammond, Nazzareno Ballatori

  • 1Department of Environmental Medicine, Box EHSC, University of Rochester School of Medicine, 575 Elmwood Avenue, Rochester, NY 14642, USA.

Insights

Multidrug resistance-associated protein 1 (MRP1) enhances the release of reduced glutathione (GSH) during apoptosis. Overexpression of MRP1 protects cells from death by maintaining stable intracellular GSH levels.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Molecular Biology

Background:

  • Reduced glutathione (GSH) export mechanisms, crucial for cellular homeostasis and apoptosis, remain largely unidentified.
  • The multidrug resistance-associated protein (MRP/ABCC) family is implicated in GSH transport, but specific roles are unclear.

Purpose of the Study:

  • To investigate the role of MRP1 in mediating reduced glutathione (GSH) efflux under basal and apoptotic conditions.
  • To determine the impact of MRP1 overexpression on intracellular GSH levels and cellular susceptibility to apoptosis.

Main Methods:

  • Stable transfection of HEK293 cells with human MRP1 to create MRP1-overexpressing cell lines.
  • Measurement of basal and apoptotic GSH efflux using Fas antibody or staurosporine to induce apoptosis.
  • Quantification of intracellular GSH levels and assessment of cellular apoptosis rates.

Main Results:

  • MRP1-overexpressing cells exhibited significantly higher GSH release under both basal and induced apoptotic conditions.
  • Intracellular GSH levels were maintained in MRP1-overexpressing cells during apoptosis, suggesting increased GSH synthesis.
  • Cells overexpressing MRP1 showed reduced susceptibility to apoptosis, indicating a protective role of stable GSH levels.

Conclusions:

  • MRP1 plays a significant role in enhancing both basal and apoptotic reduced glutathione (GSH) release.
  • MRP1-mediated GSH efflux, coupled with increased synthesis, is essential for apoptosis progression.
  • MRP1 overexpression confers a degree of protection against apoptosis, likely through maintaining intracellular GSH homeostasis.

Related Concept Videos

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...